Table 2 : Cox regression analysis for recurrence in 82 patients.


  HR P-value 95.0% CI
Lower Upper

Line of treatment
(BCG vs. docetaxel)
0.674 0. 321 0.309 1.468
Age  
(≥65 vs. <65)
3.080 0.025* 1.148 8.263
Sex  
 
(male vs. female)
0.372 0.270 0.064 2.158
Grade  
(high vs. low)
11.798 0.008* 1.907 72.981
Multiplicity
(multiple vs. single)
2.710 0.041* 1.040 7.060
Size 
(≥3 cm vs. <3 cm)
1.178 0.682 0.539 2.575

Essa et al.Journal of Cancer Therapeutics and Research  2016 5:6DOI : 10.7243/2049-7962-5-6